- About OpreX
- Synaptic Business Automation
- Profit-driven Operation
- Digital Transformation
- Industrial IoT
- Plant Security
- Operations Management
- Safe Operations
- Production Management
- Inventory Management
- Quality Management
- Asset Management
- Energy Management
- Analyzer System
- Manufacturing Operations Management
- Life Innovation
Life Innovation
Through the use of measurement, control, information technology and life science, radically improve productivity across the entire value chain, from basic research to logistics and services.
Model of our solution
Doted lines indicate Solutions under development.
-
We have 30 years of experience in this life science field and will respond to customer's problem solving with cutting-edge solutions.
-
YOKOGAWA is working on the development of single cell mass spectrometry and single cell gene analysis. In order to analyze one cell with high sensitivity, we are developing a method of collecting target cells while keeping position information under observing cells with confocal scanner.
-
Yokogawa is a proponent of a robust genetic testing method for food and drink contamination that can be carried out with overwhelming speed and simplicity. This testing method is realized through Yokogawa's high-sensitive fluorescence measurement technology developed over many years, as well as a newly developed non-label gene analysis device.
-
Employing new sensor and predictive control technologies for cell culture, we offer improved bioproduction capabilities for pharma.
-
YOKOGAWA aims to cost reductions and improve safety by providing a structure and data-management platform for unified management of information related to cellular and regenerative therapies.
-
In addition to daily improvement cycles, Yokogawa will use IIoT to support create environments that do not cause defects and that are designed to completely reduce losses.
-
Yokogawa is contributing to the development of the pharmaceutical industry based on its performance of introducing over 1,000 systems in the areas of drug substances, pharmaceutical products, and biotechnology.
In August 2017, Yokogawa announced its long-term sustainability goals (Three Goals) for the year 2050. Yokogawa established these goals to contribute to achieving Net-zero emissions, Circular economy and Well-being. In April 2018, Yokogawa strengthened the business structure of its life innovation business with the aim of achieving one of these goals, well-being.
Achieve a Well-being
- With the world’s population aging, the importance of the pharmaceutical and food industries to ensure that people can live safe and secure lives with peace of mind is growing.
- With the world’s population increasing and aging in major countries including emerging countries, it will certainly become more difficult to stably supply the necessary medical care and safe food to many people.
- In the 2030 Agenda for Sustainable Development, adopted by the United Nations in 2015, well-being is defined as a “state of physical, mental and social well being.” Yokogawa supports people’s health and prosperity, as well as a safe and comfortable workplace, in a wide range of fields, such as life sciences and drug discovery.
Establish a life innovation business
- Expand business based on existing pharmaceutical/food industry businesses and new technologies and products that are under development.
- Through the use of measurement, control, and information technology, radically improve productivity across the entire value chain, from basic research to logistics and services.
Brochures
- Life Innovation Business (2.6 MB)